"2389 Nivolumab-Induced Hepatitis: A Rare Side Effect of Programmed Cell Death-1 (PD-1) Inhibitor" by Gurjeet Kang

Selected Works of Joseph Staffetti, MD

Follow Contact

Article

2389 Nivolumab-Induced Hepatitis: A Rare Side Effect of Programmed Cell Death-1 (PD-1) Inhibitor

The American Journal of Gastroenterology (2019)

Gurjeet Kang
Dilip Ghanekar
Christopher L. Orpiano
Michael Quinn
Joseph Staffetti
Lakshminarasimhan Venu

Link

Disciplines

Medicine and Health Sciences and
Oncology

Publication Date

October 1, 2019

DOI

10.14309/01.AJG.0000599088.83306.7E

Citation Information

Gurjeet Kang, Dilip Ghanekar, Christopher L. Orpiano, Michael Quinn, et al.. "2389 Nivolumab-Induced Hepatitis: A Rare Side Effect of Programmed Cell Death-1 (PD-1) Inhibitor" The American Journal of Gastroenterology Vol. 114 Iss. 1 (2019)
Available at: http://works.bepress.com/joseph-staffetti/6/